240 related articles for article (PubMed ID: 20217483)
1. Thyroid cancer is the most common cancer associated with acromegaly.
Gullu BE; Celik O; Gazioglu N; Kadioglu P
Pituitary; 2010 Sep; 13(3):242-8. PubMed ID: 20217483
[TBL] [Abstract][Full Text] [Related]
2. Increased thyroid cancer risk in acromegaly.
Dagdelen S; Cinar N; Erbas T
Pituitary; 2014 Aug; 17(4):299-306. PubMed ID: 23836362
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study.
Gasperi M; Martino E; Manetti L; Arosio M; Porretti S; Faglia G; Mariotti S; Colao AM; Lombardi G; Baldelli R; Camanni F; Liuzzi A;
J Endocrinol Invest; 2002 Mar; 25(3):240-5. PubMed ID: 11936466
[TBL] [Abstract][Full Text] [Related]
4. The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer.
Ruchala M; Skiba A; Gurgul E; Uruski P; Wasko R; Sowinski J
Neuro Endocrinol Lett; 2009; 30(3):382-6. PubMed ID: 19855364
[TBL] [Abstract][Full Text] [Related]
5. Benign and malignant tumors in patients with acromegaly.
Barzilay J; Heatley GJ; Cushing GW
Arch Intern Med; 1991 Aug; 151(8):1629-32. PubMed ID: 1678593
[TBL] [Abstract][Full Text] [Related]
6. Complications of acromegaly: thyroid and colon.
Tirosh A; Shimon I
Pituitary; 2017 Feb; 20(1):70-75. PubMed ID: 27631334
[TBL] [Abstract][Full Text] [Related]
7. Acromegaly, growth hormone and cancer risk.
Renehan AG; Brennan BM
Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):639-57. PubMed ID: 18971124
[TBL] [Abstract][Full Text] [Related]
8. Identification of acromegalic patients at risk of developing colonic adenomas.
Bogazzi F; Cosci C; Sardella C; Costa A; Manetti L; Gasperi M; Rossi G; Bartalena L; Martino E
J Clin Endocrinol Metab; 2006 Apr; 91(4):1351-6. PubMed ID: 16449330
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors of cancers in acromegaly: a Chinese single-center retrospective study.
Xiao T; Jiao R; Yang S; Wang Y; Bai X; Zhou J; Li R; Wang L; Yang H; Yao Y; Deng K; Gong F; Pan H; Duan L; Zhu H
Endocrine; 2023 Nov; 82(2):368-378. PubMed ID: 37442901
[TBL] [Abstract][Full Text] [Related]
10. Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects.
Colao A; Marzullo P; Spiezia S; Ferone D; Giaccio A; Cerbone G; Pivonello R; Di Somma C; Lombardi G
J Clin Endocrinol Metab; 1999 Jun; 84(6):1986-91. PubMed ID: 10372698
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of thyroid disease and thyroid malignancy in acromegalic patients.
Cankurtaran Y; Örük GG; Tozduman B
Minerva Endocrinol (Torino); 2023 Jun; 48(2):130-139. PubMed ID: 33988006
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of differentiated thyroid carcinoma in acromegaly.
Tita P; Ambrosio MR; Scollo C; Carta A; Gangemi P; Bondanelli M; Vigneri R; degli Uberti EC; Pezzino V
Clin Endocrinol (Oxf); 2005 Aug; 63(2):161-7. PubMed ID: 16060909
[TBL] [Abstract][Full Text] [Related]
13. Increased epithelial cell proliferation in the colon of patients with acromegaly.
Cats A; Dullaart RP; Kleibeuker JH; Kuipers F; Sluiter WJ; Hardonk MJ; de Vries EG
Cancer Res; 1996 Feb; 56(3):523-6. PubMed ID: 8564965
[TBL] [Abstract][Full Text] [Related]
14. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of thyroid diseases in patients with acromegaly: experience of a Brazilian center.
Uchoa HB; Lima GA; Corrêa LL; Vidal AP; Cavallieri SA; Vaisman M; Buescu A; Gadelha MR
Arq Bras Endocrinol Metabol; 2013 Dec; 57(9):685-90. PubMed ID: 24402013
[TBL] [Abstract][Full Text] [Related]
16. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
[TBL] [Abstract][Full Text] [Related]
17. High incidence of thyroid cancer among patients with acromegaly.
Kaldrymidis D; Papadakis G; Tsakonas G; Kaldrymidis P; Flaskas T; Seretis A; Pantazi E; Kostoglou-Athanassiou I; Peppa M; Roussou P; Diamanti-Kandarakis E
J BUON; 2016; 21(4):989-993. PubMed ID: 27685924
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of benign and malignant tumors in patients with acromegaly at a single institute.
Kurimoto M; Fukuda I; Hizuka N; Takano K
Endocr J; 2008 Mar; 55(1):67-71. PubMed ID: 18202526
[TBL] [Abstract][Full Text] [Related]
19. Effect of two years of growth hormone and insulin-like growth factor-I suppression on prostate diseases in acromegalic patients.
Colao A; Marzullo P; Spiezia S; Giaccio A; Ferone D; Cerbone G; Di Sarno A; Lombardi G
J Clin Endocrinol Metab; 2000 Oct; 85(10):3754-61. PubMed ID: 11061535
[TBL] [Abstract][Full Text] [Related]
20. Is there an association between acromegaly and thyroid carcinoma? A critical review of the literature.
Siegel G; Tomer Y
Endocr Res; 2005; 31(1):51-8. PubMed ID: 16238191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
